Cindy B. Matsen
( out of 113 reviews )

Cindy B. Matsen, MD, MSCI

Languages spoken: English

Clinical Locations

Primary Location

Huntsman Cancer Institute - Cancer Hospital North

2K, Gynecology and Mammography
1950 Circle of Hope
Salt Lake City , UT 84112
801-213-4269
Get Directions

Sugar House Health Center

1280 E. Stringham Avenue
Salt Lake City , UT 84106
801-581-2000
Get Directions

  • Cindy B. Matsen is a fellowship trained breast surgeon at the University of Utah, Huntsman Cancer Institute. She is board certified in General Surgery and is an Associate Professor in the Department of Surgery and specializes in the surgical treatment of breast cancer and benign breast diseases. She received her undergraduate degree from the University of Oregon and her MD from the University of Chicago Pritzker School of Medicine. She then completed a residency in General Surgery at the University of Utah and a fellowship in Breast Surgical Oncology at Memorial Sloan Kettering Cancer Center in New York City. She has special interests in young breast cancer patients, doctor-patient communication, patient education, and decision making. She has research interests in shared decision making, health communication, and cancer care delivery. Her works focuses on better understanding how shared decision making is viewed and implemented by providers and designing interventions to improve the shared decision making process. She is particularly interested in preference elicitation and how better training of providers in preference elicitation techniques can improve cancer outcomes. She enjoys collaborative work and has ongoing collaborations with researchers in communication, population health, epidemiology, engineering, and molecular biology. Her overall goal is to improve our ability to provide patient-centered care for cancer patients.

    Specialties

    Board Certification

    American Board of Surgery (Sub: General Surgery)

    Patient Rating

    5.0 /5
    ( out of 113 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    HUNTSMAN CANCER CENTER

    I don't have enough good things to say about my experience with Dr. Matsen. She made me feel very comfortable, shes exceptional at patient education and my results match exactly with the expectations that she set. She is very professional, but also very personable and obviously cares about the person sitting in front of her and making a human connection. She is an excellent surgeon and also has fantastic taste in TV shows and books if you are looking for a recommendation while you recover!

    HUNTSMAN CANCER CENTER

    I was impressed at the level of care she gave me. She is very professional and knowledgeable. She treated me as a person and not a number.

    SUGAR HOUSE HEALTH CENTER

    I had a lumpectomy done through another provider and had a lot of problems with aftercare and getting the information that I needed to move forward. I switched my care to Dr. Matsen's office and she was great at explaining what my cancer entailed and providing me with information I could take home, and then setting up an action plan to move forward. I had a re-excision lumpectomy and I couldn't be more pleased. Even though I have now had two substantial lumpectomies, Dr. Matsen took care with the look of my breast. I feel like my breast now looks better than it did after the original lumpectomy. Quite the feat! She is a wonderful provider, and I would happily recommend her to friends and family in need of care.

    HUNTSMAN CANCER CENTER

    I can't even begin to explain how wonderful Dr. Matsen is! It is evident that she truly cares about her patients. She spent considerable time explaining my diagnosis and options in a very clear and concise manner. I feel well informed and comfortable about where I stand with my health. Thank you Dr. Matsen!

    SUGAR HOUSE HEALTH CENTER

    Cindy is very easy to talk to and is a good listener.

    HUNTSMAN CANCER CENTER

    Dr. Matsen is knowledgeable and interested in what she does. I can tell she puts thought into my treatment. She is also positive and encouraging to talk to.

    SUGAR HOUSE HEALTH CENTER

    Dr Matsen is a careful listener and so knowledgeable in her field. She did a thorough physical exam and gave me the information I needed so I felt empowered when I left her office.

    HUNTSMAN CANCER CENTER

    Dr Matsen is very gifted when it comes to patient care. She is personable, explains things thoroughly, and she listens and answers all my questions. Re: discussion of proposed treatment, my only issue is that there have been a couple of instances where I felt like she presented me with the worst case scenario (which for the most part I actually appreciate), but did so in a way that led me to believe it was essentially the only scenario. She suggested, for example, that I would need six months of chemotherapy prior to radiation; when I met with the medical oncologist, however, I learned that it was still unclear whether I would need chemo at all, and that even if I did it would be Q3weeks x 4 (so essentially half as long as Dr Matsen had suggested it would be). Again, I don't fault her at all for presenting it this way, I just feel like once or twice I've gotten overly worked up about something when ultimately I didn't need to.

    HUNTSMAN CANCER CENTER

    Highly recommend the Huntsman for anyone with cancer

  • Cindy B. Matsen is a fellowship trained breast surgeon at the University of Utah, Huntsman Cancer Institute. She is board certified in General Surgery and is an Associate Professor in the Department of Surgery and specializes in the surgical treatment of breast cancer and benign breast diseases. She received her undergraduate degree from the University of Oregon and her MD from the University of Chicago Pritzker School of Medicine. She then completed a residency in General Surgery at the University of Utah and a fellowship in Breast Surgical Oncology at Memorial Sloan Kettering Cancer Center in New York City. She has special interests in young breast cancer patients, doctor-patient communication, patient education, and decision making. She has research interests in shared decision making, health communication, and cancer care delivery. Her works focuses on better understanding how shared decision making is viewed and implemented by providers and designing interventions to improve the shared decision making process. She is particularly interested in preference elicitation and how better training of providers in preference elicitation techniques can improve cancer outcomes. She enjoys collaborative work and has ongoing collaborations with researchers in communication, population health, epidemiology, engineering, and molecular biology. Her overall goal is to improve our ability to provide patient-centered care for cancer patients.

    Board Certification and Academic Information

    Academic Departments Surgery -Associate Professor
    Academic Divisions Surgical Oncology
    Board Certification
    American Board of Surgery (Sub: General Surgery)

    Education history

    Undergraduate Biology - University of Oregon B.S.
    Professional Medical Medicine - University of Chicago Pritzker School of Medicine M.D.
    Residency General Surgery - University of Utah Affiliated Hospitals Resident
    Fellowship Breast Surgical Oncology - Memorial Sloan-Kettering Cancer Center Fellow
    Graduate Training Health Services Research - University of Utah M.S.C.I

    Selected Publications

    Journal Article

    1. Poruk KE, Ying J, Chidester JR, Olson JR, Matsen CB, Neumayer L, Agarwal J (2015). Breast cancer recurrence after nipple-sparing mastectomy: one institution's experience. Am J Surg, 209(1), 212-7. (Read full publication)
    2. Albright FS, Kohlmann W, Neumayer L, Buys SS, Matsen CB, Kaphingst KA, Cannon-Albright LA (2019). Population-based relative risks for specific family history constellations of breast cancer. Cancer Causes Control, 30(6), 581-590. (Read full publication)
    3. Carmichael H, Matsen C, Freer P, Kohlmann W, Stein M, Buys SS, Colonna S (2017). Breast cancer screening of pregnant and breastfeeding women with BRCA mutations. Breast Cancer Res Treat, 162(2), 225-230. (Read full publication)
    4. Frandsen J, Ly D, Cannon G, Suneja G, Matsen C, Gaffney DK, Wright M, Kokeny KE, Poppe M (2015). In the Modern Treatment Era, Is Breast Conservation Equivalent to Mastectomy in Women Younger Than 40 Years of Age? A Multi-Institution Study. International journal of radiation oncology, biology, physics, 93(5), 1096-103.
    5. Matsen CB, Luther SL, Stewart AK, Henderson WG, Kim H, Neumayer L (2012). A match made in heaven? Trying to combine ACS-NSQIP and NCDB databases. The Journal of surgical research, 175(1), 6-11. (Read full publication)
    6. Matsen CB, Ray D, Kaphingst KA, Zhang C, Presson AP, Finlayson SR (2020). Patient Satisfaction With Decision Making Does Not Correlate With Patient Centeredness of Surgeons. The Journal of surgical research, 246, 411-418. (Read full publication)
    7. Matsen CB, Hirsch A, Eaton A, Stempel M, Heerdt A, Van Zee KJ, Cody HS 3rd, Morrow M, Plitas (2014). Extent of microinvasion in ductal carcinoma in situ is not associated with sentinel lymph node metastases. Annals of surgical oncology, 21(10), 3330-5. (Read full publication)
    8. Matsen CB, Mehrara B, Eaton A, Capko D, Berg A, Stempel M, Van Zee KJ, Pusic A, King TA, Cody HS 3rd, Pilewskie M, Cordeiro P, Sclafani L, Plitas G, Gemignani ML, Disa J, El-Tamer M, Morrow (2016). Skin Flap Necrosis After Mastectomy With Reconstruction: A Prospective Study. Annals of surgical oncology, 23(1), 257-64. (Read full publication)
    9. Ugras S, Matsen C, Eaton A, Stempel M, Morrow M, Cody HS 3r (2016). Reoperative Sentinel Lymph Node Biopsy is Feasible for Locally Recurrent Breast Cancer, But is it Worthwhile?. Annals of surgical oncology, 23(3), 744-8. (Read full publication)
    10. Matsen C, Villegas K, Eaton A, Stempel M, Manning A, Cody HS, Morrow M, Heerdt (2016). Late Axillary Recurrence After Negative Sentinel Lymph Node Biopsy is Uncommon. Annals of surgical oncology, 23(8), 2456-61. (Read full publication)
    11. Taylor MA, Allen CM, Presson AP, Millar MM, Zurbuchen R, Matsen C (2019). Exploring Surgeon Variability in Recommendations for Contralateral Prophylactic Mastectomy: What Matters Most?. Annals of surgical oncology, 26(10), 3224-3231. (Read full publication)
    12. Gutnik L, Allen CM, Presson AP, Matsen C (2020). Breast Cancer Surgery Decision Role Perceptions and Choice of Surgery. Annals of surgical oncology, 27(10), 3623-3632. (Read full publication)
    13. DeRose YS, Wang G, Lin YC, Bernard PS, Buys SS, Ebbert MT, Factor R, Matsen C, Milash BA, Nelson E, Neumayer L, Randall RL, Stijleman IJ, Welm BE, Welm A (2011). Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes. Nature medicine, 17(11), 1514-20. (Read full publication)
    14. Gligorich KM, Vaden RM, Shelton DN, Wang G, Matsen CB, Looper RE, Sigman MS, Welm B (2013). Development of a screen to identify selective small molecules active against patient-derived metastatic and chemoresistant breast cancer cells. Breast cancer research, 15(4), R58. (Read full publication)
    15. Garlick JW, Olson KA, Downs-Kelly E, Bucher BT, Matsen C (2018). Secretory breast carcinoma in an 8-year-old girl: A case report and literature review. The breast journal, 24(6), 1055-1061. (Read full publication)
    16. Frandsen JE, Cannon G, Kokeny KE, Gaffney DK, Matsen C, Wright M, Poppe M (2018). Is radiation indicated for young women with early stage, node-negative breast cancer after mastectomy? A multi-institution, retrospective review. The breast journal, 24(1), 7-11. (Read full publication)
    17. Serpico V, Mone M, Zhang C, Presson A, Matsen C, Junkins S, Killian H, Porretta J, Agarwal J, Nelson (2020). Standard preoperative use of nonopioid multi-modal medications for patients undergoing mastectomy with immediate reconstruction and the effect on postoperative opioid needs. The breast journal, 26(5), 966-970. (Read full publication)
    18. Cohen AL, Factor RE, Mooney K, Salama ME, Wade M, Serpico V, Ostrander E, Nelson E, Porretta J, Matsen C, Bernard P, Boucher K, Neumayer (2017). POWERPIINC (PreOperative Window of Endocrine TheRapy Provides Information to Increase Compliance) trial: Changes in tumor proliferation index and quality of life with 7 days of preoperative tamoxifen. Breast (Edinburgh, Scotland), 31, 219-223. (Read full publication)
    19. Lum DH, Matsen C, Welm AL, Welm B (2012). Overview of human primary tumorgraft models: comparisons with traditional oncology preclinical models and the clinical relevance and utility of primary tumorgrafts in basic and translational oncology research. Current protocols in pharmacology, Chapter 14, Unit 14.22. (Read full publication)
    20. Kaphingst KA, Ivanovich J, Lyons S, Biesecker B, Dresser R, Elrick A, Matsen C, Goodman (2018). Preferences for learning different types of genome sequencing results among young breast cancer patients: Role of psychological and clinical factors. Translational behavioral medicine, 8(1), 71-79. (Read full publication)
    21. Agarwal S, Pappas L, Matsen CB, Agarwal J (2020). Second primary breast cancer after unilateral mastectomy alone or with contralateral prophylactic mastectomy. Cancer medicine, 9(21), 8043-8052. (Read full publication)
    22. Kaphingst KA, Ivanovich J, Elrick A, Dresser R, Matsen C, Goodman M (2016). How, who, and when: preferences for delivery of genome sequencing results among women diagnosed with breast cancer at a young age. Molecular genetics & genomic medicine, 4(6), 684-695. (Read full publication)
    23. Guillen KP, Fujita M, Butterfield AJ, Scherer SD, Bailey MH, Chu Z, DeRose YS, Zhao L, Cortes-Sanchez E, Yang CH, Toner J, Wang G, Qiao Y, Huang X, Greenland JA, Vahrenkamp JM, Lum DH, Factor RE, Nelson EW, Matsen CB, Poretta JM, Rosenthal R, Beck AC, Buys SS, Vaklavas C, Ward JH, Jensen RL, Jones KB, Li Z, Oesterreich S, Dobrolecki LE, Pathi SS, Woo XY, Berrett KC, Wadsworth ME, Chuang JH, Lewis MT, Marth GT, Gertz J, Varley KE, Welm BE, Welm A (2022). A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology. Nature cancer, 3(2), 232-250. (Read full publication)
    24. Jimenez RB, Johnson AE, Horick NK, Hlubocky FJ, Lei Y, Matsen CB, Mayer EL, Collyar DE, LeBlanc TW, Donelan K, Mello MM, Peppercorn J (2022). Do you mind if I record?: Perceptions and practice regarding patient requests to record clinic visits in oncology. Cancer, 128(2), 275-283. (Read full publication)
    25. Serpico VJ, Mone MC, Zhang C, Presson AP, Killian H, Agarwal J, Matsen CB, Porretta J, Nelson EW, Junkins (2021). Preoperative multimodal protocol reduced postoperative nausea and vomiting in patients undergoing mastectomy with reconstruction. Journal of plastic, reconstructive & aesthetic surgery, 75(2), 528-535. (Read full publication)
    26. Himbert C, Hathaway CA, Daniels B, Salas K, Ashworth A, Gigic B, Lin T, Viskochil R, Kirchhoff AC, Grossman D, Ose J, Tward J, Scaife C, Figueiredo JC, Toriola AT, Beck A, Shibata D, Gonzalez BD, Matsen C, Christenson C, Ma DS, Colman H, Hunt JP, Jones KB, Lee CJ, Larson M, Onega T, Akerley WL, Li CI, Schneider M, Penedo FJ, Siegel EM, Tworoger SS, Ulrich CM, Peoples A (2022). Factors associated with changes in exercise behaviors during the COVID-19 pandemic. Cancer causes & control, 33(7), 939-950. (Read full publication)
    27. Goodwin IA, Luo J, Magno-Pardon DA, Veith J, Willcockson J, Carter G, Matsen C, Kwok AC, Agarwal C (2022). Current Practices in the Pathologic Assessment of Breast Tissue in Transmasculine Chest Surgery. Plastic and reconstructive surgery, 150(3), 516e-525e. (Read full publication)
    28. Peoples AR, Oswald LB, Ose J, Daniels B, Himbert C, Hathaway CA, Gigic B, Kirchhoff AC, Lin T, Grossman D, Tward J, Varghese TK Jr, Figueiredo JC, Toriola AT, Beck A, Scaife C, Shibata D, LaStayo P, Gonzalez B, Salas K, Ashworth A, Matsen C, Christenson C, Ma DS, Colman H, Hunt JP, Jones KB, Lee CJ, Larson M, Onega T, Akerley WL, Li CI, Schneider M, Penedo FJ, Siegel EM, Tworoger SS, Ulrich C (2022). Impact of the COVID-19 pandemic on rural and urban cancer patients' experiences, health behaviors, and perceptions. The Journal of rural health, 38(4), 886-899. (Read full publication)
    29. Walker HR, Evans E, Nirula R, Hyngstrom J, Matsen C, Nelson E, Pickron B, Zurbuchen E, Morrow E (2022). "I need to have a fulfilling job": A qualitative study of surgeon well-being and professional fulfillment. American journal of surgery, 223(1), 6-11. (Read full publication)
    30. Morris BB, Smith JP, Zhang Q, Jiang Z, Hampton OA, Churchman ML, Arnold SM, Owen DH, Gray JE, Dillon PM, Soliman HH, Stover DG, Colman H, Chakravarti A, Shain KH, Silva AS, Villano JL, Vogelbaum MA, Borges VF, Akerley WL, Gentzler RD, Hall RD, Matsen CB, Ulrich CM, Post AR, Nix DA, Singer EA, Larner JM, Stukenberg PT, Jones DR, Mayo M (2022). Replicative Instability Drives Cancer Progression. Biomolecules, 12(11), (Read full publication)
    31. Teller P, Nguyen TT, Tseng J, Allen L, Matsen CB, Bellavance E, Kaufman D, Hieken T, Nagel S, Patten C, Pomerenke L, Tevis SE, Sarantou (2022). Innovation in Breast Surgery: Practical and Ethical Considerations. Annals of surgical oncology, 29(10), 6144-6150. (Read full publication)
    32. Covington MF, Hoffman JM, Morton KA, Buckway B, Boucher KM, Rosenthal R, Porretta J, Brownson KE, Matsen CB, Vaklavas C, Ward JH, Wei M, Buys SS, Chittoria N, Yakish ED, Archibald ZG, Burrell LD, Butterfield RI, Yap J (2023). Prospective Pilot Study of (18)F-Fluoroestradiol PET/CT in Patients With Invasive Lobular Carcinomas. AJR. American journal of roentgenology, 221(2), 228-239. (Read full publication)
    33. Matsen C (2015). Regional lymphatic recurrence after salvage surgery for ipsilateral breast tumor recurrence of breast cancer without local treatment for regional lymphatic basin: Ishitobi M, Matsushita A, Nakayama T, et al (Osaka Med Ctr for Cancer and Cardiovascular Diseases, Japan) J Surg Oncol 110:265-269, 2014. Journal of medical devices, 26(2), 147-149. (Read full publication)
    34. Bowen M,Matsen (2015). Local recurrence rates are low in high-risk neoadjuvant breast cancer in the I-SPY 1 trial (CALGB 150007/150012; ACRIN 6657): Cureton EL, Yau C, Alvarado MD, et al (Univ of California San Francisco; Et al) Ann Surg Oncol 21:2889-2896, 2014. Journal of medical devices, 26(1), 63-65. (Read full publication)
    35. Erickson JR,Pahlkotter MK,Thielking PD,Porretta JM,Rosenthal R,Matsen CB,Brownson K (2023). Leveraging telehealth supportive oncology services to combat COVID-19 isolation in breast cancer patients: A cancer center's perspective. Patient experience journal, 10(2), 133-137. (Read full publication)
    36. King AJ, Dunbar NM, Margolin D, Chunara R, Tong C, Jih-Vieira L, Matsen CB, Niederdeppe (2023). Global prevalence and content of information about alcohol use as a cancer risk factor on Twitter. Preventive medicine, 177, 107728. (Read full publication)
    37. Switalla KM, Boughey JC, Dimitroff K, Yau C, Ladores V, Yu H, Tchou J, Golshan M, Ahrendt G, Postlewait LM, Piltin M, Reyna CR, Matsen CB, Tuttle TM, Wallace AM, Arciero CA, Lee MC, Tseng J, Son J, Rao R, Sauder C, Naik A, Howard-McNatt M, Lancaster R, Norwood P, Esserman LJ, Mukhtar R (2024). Clipping the Positive Lymph Node in Patients with Clinically Node Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Impact on Axillary Surgery in the ISPY-2 Clinical Trial. Annals of surgical oncology, (Read full publication)
    38. Aßmann ES, Ose J, Hathaway CA, Oswald LB, Hardikar S, Himbert C, Chellam V, Lin T, Daniels B, Kirchhoff AC, Gigic B, Grossman D, Tward J, Varghese TK Jr, Shibata D, Figueiredo JC, Toriola AT, Beck A, Scaife C, Barnes CA, Matsen C, Ma DS, Colman H, Hunt JP, Jones KB, Lee CJ, Larson M, Onega T, Akerley WL, Li CI, Grady WM, Schneider M, Dinkel A, Islam JY, Gonzalez BD, Otto AK, Penedo FJ, Siegel EM, Tworoger SS, Ulrich CM, Peoples A (2024). Risk factors and health behaviors associated with loneliness among cancer survivors during the COVID-19 pandemic. Journal of behavioral medicine, 47(3), 405-421. (Read full publication)
    39. Switalla KM, Boughey JC, Dimitroff K, Yau C, Ladores V, Yu H, Tchou J, Golshan M, Ahrendt G, Postlewait LM, Piltin M, Reyna CR, Matsen CB, Tuttle T, Wallace AM, Arciero CA, Lee MC, Tseng J, Son J, Rao R, Sauder C, Naik A, Howard-McNatt M, Lancaster R, Norwood P, Esserman LJ, Mukhtar R (2024). ASO Visual Abstract: Clipping the Positive Lymph Node in Patients with Clinically Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Impact on Axillary Surgery in the ISPY-2 Clinical Trial. Annals of surgical oncology, (Read full publication)
    40. Vaklavas C, Matsen CB, Chu Z, Boucher KM, Scherer SD, Pathi S, Beck A, Brownson KE, Buys SS, Chittoria N, D'Astous E, Gulbahce HE, Henry NL, Kimani S, Porretta J, Rosenthal R, Ward J, Wei M, Welm BE, Welm A (2024). TOWARDS Study: Patient-Derived Xenograft Engraftment Predicts Poor Survival in Patients With Newly Diagnosed Triple-Negative Breast Cancer. JCO precision oncology, 8, e2300724. (Read full publication)
    41. Basik M, Cecchini RS, De Los Santos JF, Umphrey HR, Julian TB, Mamounas EP, White JR, Lucas PC, Balanoff CR, Tan AR, Weber JJ, Edmonson DA, Brown-Glaberman UA, Diego EJ, Teshome M, Matsen CB, Seaward SA, Wapnir IL, Wagner JL, Tjoe JA, Thompson AM, Wolmark (2025). Breast Tumor-Bed Biopsy for Pathological Complete Response Prediction: The NRG-BR005 Nonrandomized Clinical Trial. JAMA surgery, 160(7), 723-731. (Read full publication)
    42. Boughey JC, Yu H, Switalla K, Velle L, Lopes A, Wallace AM, Lancaster RB, Reyna CR, Tuttle TM, Jaskowiak N, Tchou J, Rao R, Lee MC, Naik AM, Golshan M, Arciero CA, Sauder CAM, Matsen CB, Yau C, Esserman L, Mukhtar RA, I-SPY2 Locoregional Working Grou (2025). Oncologic Outcomes with De-Escalation of Axillary Surgery After Neoadjuvant Chemotherapy for Breast Cancer: Results from > 1500 Patients on the I-SPY2 Clinical Trial. Annals of surgical oncology, 32(5), 3278-3291. (Read full publication)
    43. Singh P, Agnese DM, Amin M, Barrio AV, van den Bruele AB, Burke EE, Danforth DN Jr, Dirbas FM, Eladoumikdachi F, Fayanju OM, Kantor O, Kumar S, Lee MC, Matsen C, Nguyen TT, Ozmen T, Park KU, Plichta JK, Reyna C, Showalter SL, Styblo T, Tranakas N, Weiss A, Woodfin A, Laronga C, Boughey J (2025). Society of Surgical Oncology Breast Disease Site Working Group Statement on Bilateral Risk-Reducing Mastectomy: Indications, Outcomes, and Risks. Annals of surgical oncology, 32(2), 899-911. (Read full publication)
    44. Alexander A, Brown N, Horns JJ, Hardikar S, Playdon M, Das R, Driggs N, Paudel N, Matsen C, Ibele (2024). Screening Mammography Adherence Improves After Bariatric Surgery. The Journal of surgical research, 303, 476-481. (Read full publication)

    Review

    1. Matsen C, Van Zee K (2014). Use of Established Nomograms to Predict Non-Sentinel Lymph Node Metastasis. Current breast cancer reports, 6(1),
    2. Matsen CB, Neumayer L (2013). Breast cancer: a review for the general surgeon. JAMA surgery, 148(10), 971-9. (Read full publication)
    3. Singh P,Agnese D,Amin M,Barrio AV,Botty Van den Bruele A,Burke E,Danforth DN,Dirbas FM,Eladoumikdachi F,Kantor O,Kumar S,Lee MC,Matsen C,Nguyen TT,Ozmen T,Park KU,Plichta JK,Reyna C,Showalter SL,Styblo T,Tranakas N,Weiss A,Laronga C,Boughey (2024). Society of Surgical Oncology Breast Disease Site Working Group Statement on Contralateral Mastectomy: Indications, Outcomes, and Risks. Annals of surgical oncology, 31(4), 2212-2223. (Read full publication)

    Book Chapter

    1. Matsen C,Neumayer (2012). Hernia. Journal of medical devices, 919-924. (Read full publication)

    Commentary

    1. Bowen M and Matsen C (2015). Commentary on Local Recurrence Rates are Low in High-Risk Neoadjuvant Breast Cancer in the I-SPY 1 Trial (CALGB 150007/150012;ACRIN 6657). 26(1), 63-65.
    2. Matsen C (2016). Commentary on Regional Lymphatic Recurrence After Salvage Surgery for Ipsilateral Breast Tumor Recurrence of Breast Cancer Without Local Treatment for Regional Lymphatic Basin. 26(2),
    3. Matsen CB, Neumayer L (2016). Commentary on Pilewskie M, Jochelson M, Gooch J et al. ¿Is Preoperative Axillary Imaging beneficial in Identifying Clinically Node-Negative Patients Requiring Axillary Dissection?¿ J Am Coll Surg. 2016 Feb;222(2):138-45.
    4. Weitz A, Matsen C (2016). Commentary on Differences in Response and Surgical management with neoadjuvant chemotherapy in invasive lobular vs ductal breast cancer. Truin W, Vugts G,, Roumen RM, et al. Ann Surg Oncol. 2016 Jan;23(1):51-7. 27(3), 222-224.
    5. Matsen C (2016). Commentary on Locoregional Control According to Breast Cancer Subtype and Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Undergoing Breast-conserving Therapy: Swisher SK, Vila J, Tucker SL, et al (The Univ of Texas MD Anderson Cancer Ctr, Houston) Ann Surg Oncol 23:749-756, 2016. 27(4), 306-307.

    Case Report

    1. Maglic D, Moss W, Pires G, Agarwal A, Matsen C, Kwok (2021). A Case Report of Misdiagnosed Breast Implant-associated Anaplastic Large Cell Lymphoma with Lymphatic Extension. Plastic and reconstructive surgery. Global open, 9(11), e3916. (Read full publication)

    Other

    1. Himbert C, Hathaway CA, Daniels B, Salas K, Ashworth A, Gigic B, Lin T, Viskochil R, Kirchhoff AC, Grossman D, Ose J, Tward J, Scaife C, Figueiredo JC, Toriola AT, Beck A, Shibata D, Gonzalez BD, Matsen C, Christenson C, Ma DS, Colman H, Hunt JP, Jones KB, Lee CJ, Larson M, Onega T, Akerley WL, Li CI, Schneider M, Penedo FJ, Siegel EM, Tworoger SS, Ulrich CM, Peoples A (2021). Impact of the COVID-19 pandemic on exercise habits among cancer patients. (Read full publication)

    Video/Film/CD/Web/Podcast

    1. Cindy B. Matse (2015). What We Need to Know to Treat Your Breast Cancer.
    2. Cindy B. Matse (2015). What to Expect After Surgery.
    3. Cindy B. Matse (2015). Surgery for Breast Cancer.
    4. Cindy B. Matse (2015). Introduction to the Huntsman Cancer Institute's Breast Cancer Clinic.
    5. Matse (2023). Got your regular mammogram? Here's when you might want an extra checkup - Studio 5 - KSL.com, January 5, 2023 https://studio5.ksl.com/got-regular-mammogram-extra-checkup/ .

  • News & Podcasts

    Huntsman Cancer Institute News

    Podcasts